冠狀動脈支架市場報告：2030 年趨勢、預測與競爭分析

冠狀動脈支架的趨勢和預測

預計到 2030 年，全球冠狀動脈支架市場將達到 114 億美元，2024 年至 2030 年複合年成長率為 5.4%。該市場的主要驅動力是冠狀動脈疾病盛行率的上升、微創手術需求的增加以及生物可吸收血管支架的出現。全球冠狀動脈支架市場的未來可能包括醫院、心臟中心和門診手術中心市場的機會。

Lucintel 預測藥物釋放型支架將在預測期內達到最高成長。

在這個市場中，預計醫院在預測期內將出現高速成長。

預計北美地區在預測期內將出現最高的成長。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球冠狀動脈支架市場預計將達到 114 億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球冠狀動脈支架市場預計將以5.4%的複合年成長率成長。

Q3.影響市場成長的主要促進因素是：

A3.該市場的主要驅動力是冠狀動脈疾病盛行率的上升、對微創手術的需求不斷成長以及生物可吸收血管支架的出現。

Q4.市場的主要細分市場是：

A4. 冠狀動脈支架市場前景廣闊，醫院、心臟中心和門診手術中心市場充滿機會。

Q5.市場的主要企業是：

A5. 主要的冠狀動脈支架公司如下：

• Abbott Laboratories
• B. Braun Melsungen
• BIOTRONIK
• Boston
• Cook Medical

Q6.未來最大的細分市場是什麼？

A6.Lucintel預測藥物釋放型支架將在預測期內出現最高成長。

Q7.未來五年預計哪個地區的市場成長最大？

A7. 預計北美地區在預測期內成長最快。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球冠狀動脈支架市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

• 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
• 全球冠狀動脈支架市場趨勢（2018-2023）與預測（2024-2030）
• 按產品分類的全球冠狀動脈支架市場
  • 藥物釋放型支架
  • 裸金屬冠狀動脈支架
  • 生物可吸收支架
• 材質的全球冠狀動脈支架市場
  • 金屬支架
  • 鈷鉻合金
  • 鉑鉻
  • 鎳鈦
  • 不銹鋼
  • 其他
• 全球冠狀動脈支架市場（按最終用途）
  • 醫院
  • 心臟中心
  • 門診手術中心
  • 其他

第4章 2018-2030年區域市場趨勢及預測分析

• 全球冠狀動脈支架市場區域分佈
• 北美冠狀動脈支架市場
• 歐洲冠狀動脈支架市場
• 亞太冠狀動脈支架市場
• 其他地區冠狀動脈支架市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球冠狀動脈支架市場成長機會（按產品）
  • 全球冠狀動脈支架市場成長機會（按材質）
  • 全球冠狀動脈支架市場最終用途的成長機會
  • 全球冠狀動脈支架市場按地區成長機會
• 全球冠狀動脈支架市場的新興趨勢
• 戰略分析
  • 新產品開發
  • 擴大全球冠狀動脈支架市場產能
  • 全球冠狀動脈支架市場的併購和合資企業
  • 認證和許可

第7章主要企業概況

• Abbott Laboratories
• B. Braun Melsungen
• BIOTRONIK
• Boston
• Cook Medical

Coronary Stent Trends and Forecast

The future of the global coronary stent market looks promising with opportunities in the hospital, cardiac center, and ambulatory surgical center markets. The global coronary stent market is expected to reach an estimated $11.4 billion by 2030 with a CAGR of 5.4% from 2024 to 2030. The major drivers for this market are rising prevalence of coronary artery disease, escalating demand for minimally invasive procedures, and emergence of bioresorbable vascular scaffolds.

Lucintel forecasts that drug-eluting stent is expected to witness the highest growth over the forecast period.

Within this market, hospital is expected to witness the higher growth over the forecast period.

North America is expected to witness highest growth over the forecast period.

Emerging Trends in the Coronary Stent Market

The coronary stent market is well into an era of transformative change underpinned by technological, material science, and clinical practice advancement. Growing demand for minimally invasive procedures and healthcare provider interest in better patient outcomes fuels innovative trends into this arena. These changing trends are all oriented toward improved effectiveness, safety, and comfort of the patient.

• Bioabsorbable Stents: These are a class of biodegradable or bioabsorbable stents that get dissolved in the body in due course of time, thereby eliminating long-term implantation of metals within the body. This emergent trend responds to the concerns about chronic inflammation and restenosis linked with permanent stents. With time, bioabsorbable stents are gradually disappearing and reducing the risk for late stent thrombosis, along with offering an improved vessel healing.
• DES Innovations: New generations are in process, development with new, more advanced drug coatings that can elute medications much more effectively to counteract the restenosis. Enhanced drug formulation and coating technologies further improve stent performance, providing superior long-term outcomes. These innovations contribute to a reduction in the rate of vessel narrowing and minimize the need for re-interventions.
• Personalized Stent Therapy: The concepts of personalized medicine are showing a great impact on the design and delivery of stents. Tailoring stent selection and treatment methodologies based on particular characteristics of the patient, such as genetic profiling and lesion type, creates very effective and further definitive interventions. The goal of this trend is to optimize treatment outcomes and reduce complications according to individual patient factors.
• Advanced Imaging Techniques: Integration of advanced imaging modalities such as IVUS and OCT will continue to enhance the precision of stent deployment and post-procedure assessment. These technologies provide detailed insights into vessel anatomy and stent apposition, thereby enhancing decision-making during procedures and improving patient outcomes.
• Minimally Invasive Technologies: Designs for smaller, more flexible stents and their delivery systems greatly enhance the minimally invasive nature of coronary interventions. These technologies are directed at a goal of reducing procedural complications, shortening recovery times, and improving patient comfort. Innovations in catheter design and the delivery methods for stents contribute to procedures that are both safer and more efficient.

These emerging trends are collectively driving the evolution of the coronary stent market through improvements in stent technology, personalization of treatment approaches, and the use of advanced imaging modalities. As innovation in the industry proceeds, it is expected that patients will derive better safety, efficacy, and overall outcomes following coronary interventions.

Recent Developments in the Coronary Stent Market

Recent advances in the coronary stent market have taken place regarding efforts for improving patient outcomes and increasing the functionality of the stent while reducing the disadvantages of the prevailing technologies. Such a development has been made possible due to fast-progressing technology and an escalation of research. Following are five recent developments:

• New Designs for Drug-Eluting Stents: In the recent times, with the advent of newer developments, next-generation drug-eluting stents have been introduced that bring about new drug coatings and polymer technologies. This newer generation of devices is designed for more effective release of drugs over longer periods in order to reduce restenosis rates and ultimately improve long-term vessel patency. The new designs are made to ensure better outcomes for the patients and lower rates of repeat procedures.
• Improved Stent Materials: New materials, including bioresorbable polymers and novel metal alloys, were used for building more resistant and elastic stents. This is made to enhance performance by minimizing complications while ensuring good integration with the arterial wall. Advanced materials can also help solve some problems related to stent fracture and late thrombosis.
• Improved Delivery Systems: There is a development of more precise and user-friendly stent delivery systems that will enhance procedural efficiency. Innovations in catheter design, including smaller profiles and advanced navigation features, facilitate easier deployment of stents by the clinician in a safe and accurate manner. In this respect, these improvements contribute to reduced procedural time and lower risk of complications.
• Artificial Intelligence Integration: Artificial Intelligence is being integrated into the systems used for the deployment of stents to aid in real-time decision-making and enhance procedural outcomes. AI algorithms can analyze imaging data to assist in sizing, placement, and optimization of the stent for more personalized and effective treatments. This development marks a major step toward precision medicine in cardiology.
• Patient-centric: designs at the center of their focus. This involves, but is not limited to, stent designs that can reduce the occurring rate of restenosis and late complications. Development of biocompatibility has been considered in these recent works. Increasing attention is being paid to patient-centric designs, which should be employed to enhance the quality of life and overall treatment satisfaction.

These newer developments have represented significant advances in the coronary stent market, with the design of stents, materials, and delivery systems continuing to improve. Advanced technologies and treatment options that take a more patient-oriented approach will ensure a future for coronary interventions that will not only be more effective and safer but also tailored according to each patient's needs.

Strategic Growth Opportunities for Coronary Stent Market

Applications of strategic growth opportunities continue to emerge in the coronary stent market. These are propelled by technological advancement, increasing prevalence of cardiovascular diseases, and change in healthcare needs. Identification and utilization of these emerging opportunities will be paramount in driving growth and innovation for any interested market stakeholder.

• Growth Opportunity from the Expansion of Emerging Markets: Increasing access to coronary stents in emerging markets that are experiencing growth in cardiovascular diseases provides significant opportunities. Increasingly, the local production of low-priced options for these stents is improving market penetration and increasing the access of such healthcare services in these regions.
• Growth Potential: There is huge growth potential in investing in the development of next-generation drug-eluting stents that feature improved drug delivery systems and coatings. These next-generation DES possess advanced performance with lower restenosis rates and improvement in patients' outcomes.
• Bioresorbable Stents: The usage of bioresorbable stents is another significant growth opportunity, with increasing interest in their use, which gets dissolved after giving the required support to the vessel. These stents solve long-term complications associated with permanent stents and are a promising alternative for coronary interventions.
• Digital Health Technologies Integration: The introduction of digital health technologies like advanced imaging and data analytics in stenting procedures may offer new avenues for improving procedural outcomes and enhance the management of patients. Improved precision combined with real-time data can potentially lead to better stent deployment and overall treatment success.
• Approaches to personalized medicine could include the development of stents for particular patient needs. This could involve customized designs to meet diversified vessel sizes or even diversified conditions of a disease. These could also provide AVE with some avenues for growth. Personalized medicine approaches improve the efficacy and safety of treatments, so the approach meets the diverse patient populations.

Other strategic growth opportunities within the coronary stent market include expansions into emerging markets, advanced DES development, bioresorbable stents, integrations of digital health, and personalized medicine approaches. With these opportunities, innovation and market growth have been driving improvements in patient treatment, accessibility, and outcomes, shaping the future of the coronary stent industry.

Coronary Stent Market Driver and Challenges

Drivers and challenges influencing the coronary stent market include technological development, economic access, and regulatory approvals. These factors impinge on growth, innovation, and technology adoption. While the advance of technology and increasing healthcare investments drive the market, economic constraints and regulatory obstacles are overwhelming. Successful navigation through the dynamic landscape of the coronary stent market and realization of value from emerging opportunities depend on gaining insight into these drivers and challenges.

The factors responsible for driving the coronary stent market include:

1. Technological Advancements: Inventions in coronary stent technology, such as the development of bioresorbable stents and new generations of drug-eluting stents represent a significant driver for the market. Such advancement improves the performance of stents, decreases complications involving restenosis and thrombosis, and ensures better patient outcomes. Technology such as bioresorbable materials, which get dissolved over time, presents a very new and seemingly promising option compared to traditional metallic stents, ensuring lesser chronic health risks.

2. The key factors for the rising demand for effective coronary interventions are mainly due to the increasing prevalence of cardiovascular diseases, especially when populations are aging and lifestyle-related risk factors rise. This has contributed to an increasing need for advanced stent technologies in the management and treatment of coronary artery disease, among other conditions, thus driving market growth with continuous innovation in stent design and functionality.

3. Regulatory Support and Innovation Incentive: Favorable regulatory frameworks with incentives on medical device innovation are bolstering the growth of the coronary stent market. Regulatory support that works in streamlining the approval process of medical devices and offering grants or subsidies toward research and development encourages the introduction of advanced technologies of stents. This, in turn, hastens the entry of new innovations into the market and heightens competition.

Challenges in the coronary stent market are:

1. High-Cost Advanced Technologies: The high costs associated with the newer advanced coronary stent technologies of bioresorbable and next-generation DES continue to pose significant challenges in accessing these latest technologies. These will continue to impact access to the latest technologies in cost-sensitive markets. Also, high prices percolate into overall affordability and access to coronary stent treatments.

2. Overcoming regulatory: complex regulatory requirements on the one hand, and reimbursement problems for new stent technologies on the other. The time-consuming and costly process of regulatory approval, together with variable reimbursement policies across different regions, threatens to postpone entry into this market and consequently reduces the potential adoption rate of innovative stent solutions.

3. Even with these advances: coronary stents have complication and device failure risks associated with them, which include restenosis, thrombosis, and failures of devices themselves. Such complications may daunt patient outcomes and safety, thus challenging market growth. Ongoing research and improvements in stent design will be necessary to reassure confidence in the reliability of the device and thus further gain the trust of more patients.

The growth drivers for the coronary stent market include technological advancements, an increasing prevalence of cardiovascular diseases, regulatory support for the products, growing healthcare expenditure, and a shift toward minimally invasive procedures. The high costs of coronary stent technologies, tough regulatory environments, and complication risks need to be addressed to realize the full potential of the market opportunities. Identification of such factors and trends would lead to further technology advancement in coronary stents, improving patient outcomes for the continued market growth of the devices.

List of Coronary Stent Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies coronary stent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the coronary stent companies profiled in this report include-

• Abbott Laboratories
• B. Braun Melsungen
• BIOTRONIK
• Boston
• Cook Medical

Coronary Stent by Segment

The study includes a forecast for the global coronary stent by product, material, end use, and region.

Coronary Stent Market by Product [Analysis by Value from 2018 to 2030]:

• Drug-Eluting Stent
• Bare-Metal Coronary Stent
• Bioabsorbable Stent

Coronary Stent Market by Material [Analysis by Value from 2018 to 2030]:

• Metallic Stents
• Cobalt Chromium
• Platinum Chromium
• Nickel Titanium
• Stainless Steel
• Others

Coronary Stent Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers
• Others

Coronary Stent Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Coronary Stent Market

The coronary stent market is hereby set to record development across its major global economies. Changes in stent technology, modifications in regulatory frameworks, and the altering healthcare needs are setting the mark on market dynamics. These recent developments mirror the improvement of design and functionality of the stents and improvement in patient outcomes driven by the latest technology and changing demographic trends.

• United States: In the U.S., some of the new entrants are bioresorbable stents and newer DES. All these developments have been intended to overcome the long-term complications of traditional metallic stents. Next-generation DES, that boast of better safety profiles with lesser risk of restenosis, is seeing increased uptake in the U.S. market. Advanced imaging integrated into the placement of stents is enhancing procedural precision and improving patient outcomes.
• China: The coronary stent market in China is growing rapidly, with a high degree of emphasis on affordability and accessibility. Recent development bearing testimony to the same includes the expansion of local manufacturing capabilities in and cost-effective stent options. Chinese companies further enhance stent technology through innovations in design and materials for better performance and fewer complications. Government support for medical device innovation is accelerating the pace of growth of this market and widening the spread of sophisticated stent technologies across the country.
• Germany: Germany is among the leading countries in adopting the latest stent technologies, which includes bioresorbable stents and advanced drug coatings on stents. It has also been trying to integrate the concept of digital health within stent-related procedures, including advanced imaging and data analytics, which would further enhance patient outcomes and improve procedural efficiency. The tight regulatory environment in Germany ensures that only high-quality stents are approved, thus contributing to high standards in coronary interventions.
• India: The coronary stent market is continuously booming in India due to rising cardiovascular diseases and the advancement of stent technologies. This includes recent advancements in affordable varieties of stents and improvements in the design of drug-eluting stents. Indian companies are investing in research and development to manufacture innovative solutions for better access and efficiency in disease treatment among the population.
• Japan: The Japanese market is one of the technologically innovative ones with huge emphases on patient-specific solutions. Some recent developments in this regard include the designing of high-performance stents with increased biocompatibility and drug delivery mechanisms. New material use and design approaches are being made to further the functionality of the stent for better patient safety. The strong health care structure supports the rapid use of such advanced technologies with respect to stents and continuous improvement in coronary intervention practices.

Features of the Global Coronary Stent Market

Market Size Estimates: Coronary stent market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Coronary stent market size by product, material, end use, and region in terms of value ($B).

Regional Analysis: Coronary stent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, materials, end uses, and regions for the coronary stent market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the coronary stent market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the coronary stent market size?

Answer: The global coronary stent market is expected to reach an estimated $11.4 billion by 2030.

Q2. What is the growth forecast for coronary stent market?

Answer: The global coronary stent market is expected to grow with a CAGR of 5.4% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the coronary stent market?

Answer: The major drivers for this market are rising prevalence of coronary artery disease, escalating demand for minimally invasive procedures, and emergence of bioresorbable vascular scaffolds.

Q4. What are the major segments for coronary stent market?

Answer: The future of the coronary stent market looks promising with opportunities in the hospital, cardiac center, and ambulatory surgical center markets.

Q5. Who are the key coronary stent market companies?

Answer: Some of the key coronary stent companies are as follows:

• Abbott Laboratories
• B. Braun Melsungen
• BIOTRONIK
• Boston
• Cook Medical

Q6. Which coronary stent market segment will be the largest in future?

Answer: Lucintel forecasts that drug-eluting stent is expected to witness the highest growth over the forecast period.

Q7. In coronary stent market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the coronary stent market by product (drug-eluting stent, bare-metal coronary stent, and bioabsorbable stent), material (metallic stents, cobalt chromium, platinum chromium, nickel titanium, stainless steel, and others), end use (hospitals, cardiac centers, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Coronary Stent Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Coronary Stent Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Coronary Stent Market by Product
  • 3.3.1: Drug-Eluting Stent
  • 3.3.2: Bare-Metal Coronary Stent
  • 3.3.3: Bioabsorbable Stent
• 3.4: Global Coronary Stent Market by Material
  • 3.4.1: Metallic Stents
  • 3.4.2: Cobalt Chromium
  • 3.4.3: Platinum Chromium
  • 3.4.4: Nickel Titanium
  • 3.4.5: Stainless Steel
  • 3.4.6: Others
• 3.5: Global Coronary Stent Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Cardiac Centers
  • 3.5.3: Ambulatory Surgical Centers
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Coronary Stent Market by Region
• 4.2: North American Coronary Stent Market
  • 4.2.1: North American Coronary Stent Market by Product: Drug-Eluting Stent, Bare-Metal Coronary Stent, and Bioabsorbable Stent
  • 4.2.2: North American Coronary Stent Market by End Use: Hospitals, Cardiac Centers, Ambulatory Surgical Centers, and Others
• 4.3: European Coronary Stent Market
  • 4.3.1: European Coronary Stent Market by Product: Drug-Eluting Stent, Bare-Metal Coronary Stent, and Bioabsorbable Stent
  • 4.3.2: European Coronary Stent Market by End Use: Hospitals, Cardiac Centers, Ambulatory Surgical Centers, and Others
• 4.4: APAC Coronary Stent Market
  • 4.4.1: APAC Coronary Stent Market by Product: Drug-Eluting Stent, Bare-Metal Coronary Stent, and Bioabsorbable Stent
  • 4.4.2: APAC Coronary Stent Market by End Use: Hospitals, Cardiac Centers, Ambulatory Surgical Centers, and Others
• 4.5: ROW Coronary Stent Market
  • 4.5.1: ROW Coronary Stent Market by Product: Drug-Eluting Stent, Bare-Metal Coronary Stent, and Bioabsorbable Stent
  • 4.5.2: ROW Coronary Stent Market by End Use: Hospitals, Cardiac Centers, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Coronary Stent Market by Product
  • 6.1.2: Growth Opportunities for the Global Coronary Stent Market by Material
  • 6.1.3: Growth Opportunities for the Global Coronary Stent Market by End Use
  • 6.1.4: Growth Opportunities for the Global Coronary Stent Market by Region
• 6.2: Emerging Trends in the Global Coronary Stent Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Coronary Stent Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Coronary Stent Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: B. Braun Melsungen
• 7.3: BIOTRONIK
• 7.4: Boston
• 7.5: Cook Medical